This content is machine translated Research PTX3 contributes to trastuzumab-induced cardiac complications Trastuzumab, the first humanized monoclonal antibody targeting human epidermal growth factor receptor 2 (ERBB2/HER2), is currently used as first-line therapy for HER2(+) tumors. However, trastuzumab increases the risk of cardiac…
View Post 7 min This content is machine translated HER2-positive breast carcinoma New substances enable targeted therapy The HER2 receptor belongs to the family of four transmembrane receptor tyrosine kinases (EGFR/HER1, HER2, HER3, and HER4) that influence cell growth, differentiation, and survival. Overexpression of HER2 occurs in…
